Jacobi Capital Management LLC Astrazeneca PLC Transaction History

Jacobi Capital Management LLC

$1.29 Billion
Q3 2024

A detailed history of Jacobi Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jacobi Capital Management LLC holds 10,033 shares of AZN stock, worth $658,465. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,033

Previous 9,961 0.72%

Holding current value

$658,465

Previous $776,000 0.64%

% of portfolio

0.06%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $5,520 - $6,308	72 Added 0.72%	10,033 $781,000
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $13,228 - $16,004	-198 Reduced 1.95%	9,961 $776,000
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $174,545 - $198,970	2,860 Added 39.18%	10,159 $688,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $95,310 - $106,691	1,540 Added 26.74%	7,299 $491,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $1,491 - $1,649	-23 Reduced 0.4%	5,759 $389,000
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $50,335 - $54,583	-720 Reduced 11.07%	5,782 $413,000
Q1 2023 May 05, 2023	SELL	$63.15 - $71.6 $17,492 - $19,833	-277 Reduced 4.09%	6,502 $451,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $5,746 - $7,466	-106 Reduced 1.54%	6,779 $459,000
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $5,248 - $13,439	-99 Reduced 1.42%	6,885 $378,000
Q1 2022 May 06, 2022	SELL	$55.72 - $67.12 $22,622 - $27,250	-406 Reduced 5.49%	6,984 $463,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $8,913 - $10,531	-165 Reduced 2.18%	7,390 $430,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $16,501 - $18,054	-297 Reduced 3.78%	7,555 $454,000
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $36,596 - $42,245	776 Added 10.97%	7,852 $390,000
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $59,194 - $70,784	1,220 Added 20.83%	7,076 $354,000
Q3 2020 Oct 30, 2020	SELL	$53.07 - $61.1 $17,460 - $20,101	-329 Reduced 5.32%	5,856 $321,000
Q2 2020 Jul 27, 2020	BUY	$43.1 - $55.31 $1,508 - $1,935	35 Added 0.57%	6,185 $327,000
Q1 2020 Apr 24, 2020	SELL	$37.79 - $51.33 $24,110 - $32,748	-638 Reduced 9.4%	6,150 $275,000
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $722 - $818	18 Added 0.27%	6,788 $303,000
Q2 2019 Aug 07, 2019	BUY	$37.28 - $41.68 $3,056 - $3,417	82 Added 1.23%	6,770 $279,000
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $8,978 - $10,884	253 Added 3.93%	6,688 $270,000
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $40,029 - $45,058	-1,086 Reduced 14.44%	6,435 $244,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $102,298 - $116,895	-2,943 Reduced 28.13%	7,521 $298,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $84,302 - $90,402	2,440 Added 30.41%	10,464 $367,000
Q1 2018 May 03, 2018	BUY	$32.97 - $36.63 $189,544 - $210,585	5,749 Added 252.7%	8,024 $278,000
Q3 2017 Nov 02, 2017	BUY	$28.96 - $34.0 $45,467 - $53,380	1,570 Added 222.7%	2,275 $78,000
Q2 2017 Aug 10, 2017	BUY	N/A	705	705 $24,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Astrazeneca PLC Transaction History